E. Berman et al., A MULTIDISCIPLINARY APPROACH TO TOXICOLOGICAL SCREENING .1. SYSTEMIC TOXICITY, Journal of toxicology and environmental health, 45(2), 1995, pp. 127-143
The toxicity of 10 chemicals, including pesticides (carbaryl, chlordan
e, heptachlor, and triadimefon), solvents (carbon tetrachloride, dichl
oromethane, tetrachloroethylene, and trichloroethylene), and industria
l chemicals [diethylhexylphthalate (DEHP) and phenol] was examined in
the liver, kidneys, spleen, thymus, and adrenals of female F344 rats a
fter 1 or 14 d of oral dosing. For each chemical, 4 doses were based o
n fractions of the acute LD50, which was estimated using an abbreviate
d (up-and-down) method. A multivariate analysis (MANOVA) was conducted
for each organ using selected measures of toxicity. A post hoc contra
st analysis was also conducted for significant MANOVA results in order
to determine effective and ineffective doses. A single dose of heptac
hlor resulted in necrotic lymphocytes in the spleen and thymus at dose
s greater than or equal to 23 mg/kg. Triadimefon altered liver and spl
een weights; this effect has not been described previously. Dichlorome
thane (greater than or equal to 337 mg/kg/d for 14 d) increased the in
cidence of necrosis of individual centrilobular hepatocytes. Trichloro
ethylene-induced hepatotoxicity was obtained at doses an order of magn
itude lower than those reported in the literature. Acute DEHP (150 mg/
kg) increased mitotic figures in hepatocytes, which were replaced by h
epatocellular cytomegaly after 14 d of dosing at the same level. Follo
wing phenol exposure, there was an increased incidence in hepatocellul
ar necrosis at 1 d, and an increased incidence of kidney lesions at 1
and 14 d; these findings were considered to be the result of vascular
stasis. Overall, the algorithm used to select doses was effective for
both 1- or 14-d dosing regimens. For all chemicals except carbon tetra
chloride, the lowest effective dose for systemic toxicity was within t
he range of 3-56 % of the LD50 for acute dosing, and 1-30 % of the LD5
0 for repeated administration.